QIPT PE Ratio & Valuation,Is QIPT Overvalued

QIPT Relative Valuation

QIPT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, QIPT is overvalued; if below, it's undervalued.

Historical Valuation

Quipt Home Medical Corp (QIPT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.39 is considered Undervalued compared with the five-year average of 2.07. The fair price of Quipt Home Medical Corp (QIPT) is between 6.02 to 12.34 according to relative valuation methord. Compared to the current price of 3.51 USD , Quipt Home Medical Corp is Undervalued By 41.67%.

Relative Value

Fair Zone

6.02-12.34

Current Price：3.51

41.67%

Undervalued

-14.46

3.09

EV/EBITDA

Quipt Home Medical Corp. (QIPT) has a current EV/EBITDA of 3.09. The 5-year average EV/EBITDA is 4.63. The thresholds are as follows: Strongly Undervalued below 1.65, Undervalued between 1.65 and 3.14, Fairly Valued between 6.12 and 3.14, Overvalued between 6.12 and 7.61, and Strongly Overvalued above 7.61. The current Forward EV/EBITDA of 3.09 falls within the Undervalued range.

-144.40

EV/EBIT

Quipt Home Medical Corp. (QIPT) has a current EV/EBIT of -144.40. The 5-year average EV/EBIT is 14.58. The thresholds are as follows: Strongly Undervalued below -96.01, Undervalued between -96.01 and -40.71, Fairly Valued between 69.88 and -40.71, Overvalued between 69.88 and 125.18, and Strongly Overvalued above 125.18. The current Forward EV/EBIT of -144.40 falls within the Strongly Undervalued range.

0.39

Quipt Home Medical Corp. (QIPT) has a current PS of 0.39. The 5-year average PS is 0.86. The thresholds are as follows: Strongly Undervalued below -0.01, Undervalued between -0.01 and 0.43, Fairly Valued between 1.30 and 0.43, Overvalued between 1.30 and 1.73, and Strongly Overvalued above 1.73. The current Forward PS of 0.39 falls within the Undervalued range.

0.00

P/OCF

Quipt Home Medical Corp. (QIPT) has a current P/OCF of 0.00. The 5-year average P/OCF is 4.58. The thresholds are as follows: Strongly Undervalued below -3.34, Undervalued between -3.34 and 0.62, Fairly Valued between 8.54 and 0.62, Overvalued between 8.54 and 12.50, and Strongly Overvalued above 12.50. The current Forward P/OCF of 0.00 falls within the Undervalued range.

0.00

P/FCF

Quipt Home Medical Corp. (QIPT) has a current P/FCF of 0.00. The 5-year average P/FCF is 8.97. The thresholds are as follows: Strongly Undervalued below -12.04, Undervalued between -12.04 and -1.53, Fairly Valued between 19.47 and -1.53, Overvalued between 19.47 and 29.98, and Strongly Overvalued above 29.98. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Quipt Home Medical Corp (QIPT) has a current Price-to-Book (P/B) ratio of 1.11. Compared to its 3-year average P/B ratio of 1.56 , the current P/B ratio is approximately -28.90% higher. Relative to its 5-year average P/B ratio of 2.38, the current P/B ratio is about -53.45% higher. Quipt Home Medical Corp (QIPT) has a Forward Free Cash Flow (FCF) yield of approximately 21.04%. Compared to its 3-year average FCF yield of 19.72%, the current FCF yield is approximately 6.66% lower. Relative to its 5-year average FCF yield of 15.20% , the current FCF yield is about 38.39% lower.

1.11

P/B

Median3y

1.56

Median5y

2.38

21.04

FCF Yield

Median3y

19.72

Median5y

15.20

Competitors Valuation Multiple

The average P/S ratio for QIPT's competitors is 1.40, providing a benchmark for relative valuation. Quipt Home Medical Corp Corp (QIPT) exhibits a P/S ratio of 0.39, which is -72.31% above the industry average. Given its robust revenue growth of -4.07%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of QIPT decreased by 14.43% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -2.63 to -5.19.

The secondary factor is the Revenue Growth, contributed -4.07%to the performance.

Overall, the performance of QIPT in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-4.07%

60.76M → 58.29M

Revenue Growth

97.34%

-2.63 → -5.19

Margin Expansion

-107.70%

141.85 → -10.92

P/E Change

-14.43%

3.05 → 2.61

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Quipt Home Medical Corp (QIPT) currently overvalued or undervalued?

What is Quipt Home Medical Corp (QIPT) fair value?

QIPT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Quipt Home Medical Corp (QIPT) is between 6.02 to 12.34 according to relative valuation methord.

How does QIPT's valuation metrics compare to the industry average?

What is the current P/B ratio for Quipt Home Medical Corp (QIPT) as of Dec 15 2025?

As of Dec 15 2025, Quipt Home Medical Corp (QIPT) has a P/B ratio of 1.11. This indicates that the market values QIPT at 1.11 times its book value.

What is the current FCF Yield for Quipt Home Medical Corp (QIPT) as of Dec 15 2025?

As of Dec 15 2025, Quipt Home Medical Corp (QIPT) has a FCF Yield of 21.04%. This means that for every dollar of Quipt Home Medical Corp’s market capitalization, the company generates 21.04 cents in free cash flow.

What is the current Forward P/E ratio for Quipt Home Medical Corp (QIPT) as of Dec 15 2025?

As of Dec 15 2025, Quipt Home Medical Corp (QIPT) has a Forward P/E ratio of -14.46. This means the market is willing to pay $-14.46 for every dollar of Quipt Home Medical Corp’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Quipt Home Medical Corp (QIPT) as of Dec 15 2025?

As of Dec 15 2025, Quipt Home Medical Corp (QIPT) has a Forward P/S ratio of 0.39. This means the market is valuing QIPT at $0.39 for every dollar of expected revenue over the next 12 months.

QIPT Valuation